The Vector Core
produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community.
Getting Started
To begin work with the Vector Core, you will first need to register with MiCores and complete training. Please see the Training page for more information on how to get started.
Consultation
For questions regarding your specific needs or project goals please contact Vector Core Director, Tom Lanigan, to set up a consultation.
Ordering
Please visit the Products & Services page for more detailed information on what we offer. To request products and services, login to MiCores.
Core Objectives
- Provide a Core laboratory for the construction, purification, and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies.
- Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies.
- Maintain qualified staff and provide high quality, cost-effective products to our researchers.
General Information
734-647-1351
Our People
Email Us
News
-
BRCF Core Holiday Hours for November 2023
In observance of the upcoming November holidays, many of our cores have adjusted their operations. If you have questions about hours or access, please use the core’s contact information listed below. Advanced Genomics Core Core services will be unavailable after …
Breaking News -
AGC Onboards Xenium!
The Advanced Genomics Core has acquired the 10x Genomics Xenium, an instrument that enables transcriptomic analysis at a subcellular level while maintaining spatial context. This technology comes with pre-validated biologically relevant targets for tissue panels, and up to 100 additional …
Products Breaking News AGC Blog Posts